141 related articles for article (PubMed ID: 29095978)
1. Personalized Cancer Vaccines Advance in the Clinic.
Schmidt C
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29095978
[No Abstract] [Full Text] [Related]
2. Personalized cancer vaccines: adjuvants are important, too.
Gouttefangeas C; Rammensee HG
Cancer Immunol Immunother; 2018 Dec; 67(12):1911-1918. PubMed ID: 29644387
[TBL] [Abstract][Full Text] [Related]
3. Cancer Vaccine Week, an international symposium 5-9 October 1998, New York, NY.
Pawelec G
Cancer Immunol Immunother; 1999 Feb; 47(6):352-6. PubMed ID: 10203066
[No Abstract] [Full Text] [Related]
4. How does a cancer vaccine work?
Drew L
Nature; 2024 Mar; 627(8005):S34-S35. PubMed ID: 38538946
[No Abstract] [Full Text] [Related]
5. Conference on cancer vaccines.
Schadendorf D; Belardelli F; Ferrantini M; Parmiani G; Colombo MP
Cancer Immunol Immunother; 2000 Jul; 49(4-5):281-4. PubMed ID: 10941912
[No Abstract] [Full Text] [Related]
6. Strategies for immune therapy: Würzburg, Germany, 29 February-3 March 2004.
Pawelec G; Gouttefangeas C
Cancer Immunol Immunother; 2004 Aug; 53(8):755-8. PubMed ID: 15133632
[No Abstract] [Full Text] [Related]
7. Tumor vaccines and beyond.
Melenhorst JJ; Barrett AJ
Cytotherapy; 2011 Jan; 13(1):8-18. PubMed ID: 21067312
[TBL] [Abstract][Full Text] [Related]
8. How personalized cancer vaccines could keep tumours from coming back.
Dolgin E
Nature; 2024 Jun; 630(8016):290-292. PubMed ID: 38862759
[No Abstract] [Full Text] [Related]
9. Recent Findings on Therapeutic Cancer Vaccines: An Updated Review.
Sheikhlary S; Lopez DH; Moghimi S; Sun B
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672519
[TBL] [Abstract][Full Text] [Related]
10. Personalized neoantigen cancer vaccines: An analysis of the clinical and commercial potential of ongoing development programs.
Perrinjaquet M; Richard Schlegel C
Drug Discov Today; 2023 Nov; 28(11):103773. PubMed ID: 37730103
[TBL] [Abstract][Full Text] [Related]
11. How should clinical data be included in experimental studies of cancer immunology?
Gjertsen BT; Bruserud Ø
Cancer Immunol Immunother; 2004 Aug; 53(8):677-80. PubMed ID: 15069584
[TBL] [Abstract][Full Text] [Related]
12. Personalized cancer vaccines pass first major clinical test.
Dolgin E
Nat Rev Drug Discov; 2023 Aug; 22(8):607-609. PubMed ID: 37438497
[No Abstract] [Full Text] [Related]
13. Toward next-generation cancer immunotherapy: 10th annual meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 23-25, 2012.
Kloke BP; Kutscher S; Rae R; Kvistborg P; Britten CM; Hadrup SR
Cancer Immunol Immunother; 2013 May; 62(5):975-81. PubMed ID: 23299564
[No Abstract] [Full Text] [Related]
14. Identification of personalized cancer neoantigens with HANSolo.
Cattaneo CM
Nat Rev Cancer; 2023 Dec; 23(12):800. PubMed ID: 37704741
[No Abstract] [Full Text] [Related]
15. Personalized cancer T-cell therapy takes the stage, mirroring vaccine success.
Chiffelle J; Harari A
J Exp Med; 2024 Aug; 221(8):. PubMed ID: 38861029
[TBL] [Abstract][Full Text] [Related]
16. The fifteenth International Conference on Progress in Vaccination against Cancer (PIVAC-15), 6-8 October 2015, Tübingen, Germany: looking back on 15 years of progress.
Shipp C; Pawelec G
Cancer Immunol Immunother; 2017 Feb; 66(2):273-279. PubMed ID: 27557906
[No Abstract] [Full Text] [Related]
17. "It is the antigen(s), stupid" and other lessons from over a decade of vaccitherapy of human cancer.
Buckwalter MR; Srivastava PK
Semin Immunol; 2008 Oct; 20(5):296-300. PubMed ID: 18715801
[TBL] [Abstract][Full Text] [Related]
18. International conference: progress in vaccination against cancer (PIVAC) 2002, Nottingham, UK.
Rees RC; Robins RA; Pawelec G; Muller L; Li G; Spendlove I
Cancer Immunol Immunother; 2003 Jun; 52(6):403-7. PubMed ID: 12684847
[No Abstract] [Full Text] [Related]
19. The Thirteenth International Conference on Progress in Vaccination Against Cancer (PIVAC-13), October 2-4, 2013, Amsterdam, The Netherlands: the current standing of anti-tumor immunotherapeutic approaches.
Melief SM; Visconti VV; Doorduijn EM; Santegoets SJ
Cancer Immunol Immunother; 2014 Oct; 63(10):1105-12. PubMed ID: 24619351
[No Abstract] [Full Text] [Related]
20. Cancer-vaccine trials give reasons for optimism.
Drew L
Nature; 2024 Mar; 627(8005):S33. PubMed ID: 38538945
[No Abstract] [Full Text] [Related]
[Next] [New Search]
